Scholarly publications and presentations by Rochester Regional Health's Research department authors.
Submissions from 2024
3-1-2024 Serotype 3 Antibody Response and Antibody Functionality Compared to Serotype 19A Following 13-Valent Pneumococcal Conjugate Immunization in Children, Naoko Fuji, Rochester Regional Health, Minh Pham, Department of Decision Sciences, Lam Family College of Business, San Francisco State University, San Francisco, California., Ravinder Kaur, Rochester Regional Health, et al.
Submissions from 2023
12-21-2023 Age-Stratified Investigation of Sleep Disorders and PTSD Prevalence Among Vietnam Veterans, Thomas Chacko, Rochester Regional Health, Sara Mithani, Melissa Bunker, et al.
12-21-2023 A Knowledge-Driven Bio-Behavioral Network Model of the Inflammasome and Caloric Restriction, Thomas Chacko, Rochester Regional Health, Gordon Broderick, Rochester Regional Health, Nadia Moore, Rochester Regional Health, et al.
12-1-2023 1688. Naturally-induced Serum Antibody Levels in Children to Pneumococcal Polysaccharide 15B that Correlate with Protection from Nasopharyngeal Colonization but Anti-serotype 15B Antibody has Low Functional Cross-reactivity with Serotype 15C, Ravinder Kaur, Rochester Regional Health, Eduardo Gonzalez, Rochester Regional Health, Minh Pham, et al.
12-1-2023 1725. Differences in serotype 3 antibody response and antibody functionality compared to serotype 19A following 13-valent pneumococcal conjugate immunization in children, Naoko Fuji, Rochester Regional Health, Minh Pham, Ravinder Kaur, Rochester Regional Health, et al.
12-1-2023 A stronger association of depression with rheumatoid arthritis in presence of obesity and hypertriglyceridemia, Grayden Shand, David D. Reh School of Business, Clarkson University, Potsdam, NY, United States., Daniel T. Fuller, Department of Mathematics, Clarkson University, Potsdam, NY, United States., Leon Lufkin, The Clarkson School, Clarkson University, Potsdam, NY, United States., et al.
11-22-2023 Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C, Ravinder Kaur, Rochester Regional Health, Eduardo Gonzalez, Rochester Regional Health, Minh Pham, et al.
11-1-2023 Liver Abscesses Due to Fusobacterium nucleatum: A Case Series, Ahmed Elkhapery, Rochester Regional Health, Sheza Malik, Rochester Regional Health, Pratibha Chaudhary, Rochester Regional Health, et al.
11-1-2023 Variability of vaccine responsiveness in early life, Michael E. Pichichero, Rochester Regional Health
10-27-2023 A regulatory pathway model of neuropsychological disruption in Havana syndrome, Thomas P. Chacko, Rochester Regional Health, J Tory Toole, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, et al.
10-26-2023 Very early life microbiome and metabolome correlates with primary vaccination variability in children, Michael Shaffer, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., Katharine Best, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., Catherine Tang, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., et al.
8-1-2023 Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections, Ravinder Kaur, Rochester Regional Health, Jill Mangiafesto, Rochester Regional Health, Karin Pryharski, Rochester Regional Health, et al.
4-18-2023 Colonization, Density, and Antibiotic Resistance of Streptococcus pneumoniae, Haemophilus Influenzae, and Moraxella catarrhalis among PCV13-Vaccinated Infants in the First Six Months of Life in Rochester, New York: A Cohort Study, Ravinder Kaur, Rochester Regional Health and Michael Pichichero, Rochester Regional Health
2-1-2023 Vaccine target and carrier molecule nontypeable Haemophilus influenzae protein D dimerizes like the close Escherichia coli GlpQ homolog but unlike other known homolog dimers, Seth P. Jones, School of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, New York, USA., Kali H. Cook, School of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, New York, USA., Melody L. Holmquist, National Technical Institute for the Deaf, Rochester Institute of Technology, Rochester, New York, USA., et al.
2-1-2023 Window of Susceptibility to Acute Otitis Media Infection, Peter Bajorski, School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York., Naoko Fuji, Rochester Regional Health, Ravinder Kaur, Rochester Regional Health, et al.
1-1-2023 Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines, Michael Pichichero, Rochester Regional Health, Richard Malley, Boston Children's Hospital, Division of Infectious Diseases, Boston Massachusetts, Ravinder Kaur, Rochester Regional Health, et al.
Submissions from 2022
12-1-2022 Haemophilus influenzae Protein D antibody suppression in a multi-component vaccine formulation, Lea V. Michel, School of Chemistry and Materials Science, Rochester Institute of Technology, NY, USA., Ravinder Kaur, Rochester Regional Health, Michael L. Gleghorn, School of Chemistry and Materials Science, Rochester Institute of Technology, NY, USA., et al.
12-2022 Refinement of Biological Regulatory Graphs using Functional Enrichment, Jeffrey M. Page, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, Gary Skuse, Rochester Regional Health, et al.
10-19-2022 Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model, Naoko Fuji, Rochester Regional Health; Michael Pichichero, Rochester Regional Health; and Ravinder Kaur, Rochester Regional Health
10-10-2022 Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm, Spencer Richman, Rochester Regional Health, Cole Lyman, Rochester Regional Health, Anastasia Nesterova, Elsevier BV, Biology Solutions, Amsterdam, the Netherlands., et al.
10-1-2022 Developing patient-centered outcomes research infrastructure in a rural community through patient and stakeholder engagement and education during the COVID-19 pandemic, Carly Lovelett, Rochester Regional Health, Michelle Medeiros, The PATIENTS Program, University of Maryland School of Pharmacy, Baltimore, MD, USA., Daniel Jaremczuk, Rochester Regional Health, et al.
7-26-2022 Mapping the network biology of metabolic response to stress in posttraumatic stress disorder and obesity, Thomas P. Chacko, Rochester Regional Health, J Tory Toole, Rochester Regional Health, Spencer Richman, Rochester Regional Health, et al.
7-12-2022 Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer, Eileen H. Shinn, The University of Texas MD Anderson Cancer Center, Houston, TX, Brooke E. Busch, The University of Texas MD Anderson Cancer Center, Houston, TX, Neda Jasemi, The University of Texas MD Anderson Cancer Center, Houston, TX, et al.
5-19-2022 Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection, Ravinder Kaur, Rochester Regional Health and Michael E. Pichichero, Rochester Regional Health
5-1-2022 Antibiotic Use and Vaccine Antibody Levels, Timothy J. Chapman, Rochester Regional Health, Minh Pham, School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York., Peter Bajorski, School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York., et al.